Elisabeth Meedt
Regensburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Multicenter validation of the newly developed Concise Objectifiable Risk Evaluation (CORE) score also confirms its ability to complement the Hematopoietic Cell Comorbidity Index (HCT-CI).
Journal: Bone marrow transplantation
Published: September 15, 2025
"The antibiotic paradox" in allogeneic stem cell transplantation.
Journal: Bone marrow transplantation
Published: April 28, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration.
Journal: Nature communications
Published: November 19, 2024
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis.
Journal: Oncoimmunology
Published: January 03, 2024
Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation.
Journal: Visceral medicine
Published: December 19, 2023
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis.
Journal: Annals of hematology
Published: November 29, 2023
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation.
Journal: Nature cancer
Published: March 08, 2023
Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 25, 2023
Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD.
Journal: Cell reports. Medicine
Published: February 01, 2023
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 15, 2022
Last Updated: 09/26/2026